visualizations
Bellam, Naveen, MD
Overview
overview
- Dr. Bellam is trained to care for patients requiring treatment for end-stage heart failure with the possibility of needing heart transplantation. His clinical specialties include management of patients with end-stage heart failure, cardiogenic shock, mechanical circulatory support (VAD), pulmonary hypertension, ventricular assist devices, and heart transplantation. Dr. Bellam sees patients both pre- and post-transplant to ensure they receive the best care and healing possible. His research has focused on risk stratification and improving disease management in patients with cardiovascular disease and heart failure. He has presented multiple publications locally and internationally. He is board-certified in Internal Medicine, Cardiovascular Disease, and Echocardiography. Dr. Bellam is a member of the American College of Cardiology (ACC), International Society of Heart and Lung Transplantation (ISHLT), and the Heart Failure Society of America (HFSA).
Affiliation
Member of
-
Clinical Program
-
Research Department
Publications
Most Recent Publications
-
2021Navigating Early Careers in Heart Failure in the Era of Novel Coronavirus Disease-2019. JOURNAL OF CARDIAC FAILURE. 27:97-99.Full Text via DOI: 10.1016/j.cardfail.2020.11.010 PMID: 33227417
-
2016Educating the Next Generation of Peer Reviewers. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2079-2080.Full Text via DOI: 10.1016/j.jacc.2016.03.483 PMID: 27126536
-
2015Long-Term Prognosis After Coronary Artery Calcification Testing in Asymptomatic Patients A Cohort Study. ANNALS OF INTERNAL MEDICINE. 163:14-21.Full Text via DOI: 10.7326/M14-0612 PMID: 26148276
-
2015Team-Based Care for Managing Cardiac Comorbidities in Heart Failure. HEART FAILURE CLINICS. 11:407-+.Full Text via DOI: 10.1016/j.hfc.2015.03.005 PMID: 26142638
-
2014Prognostic significance of calcified plaque among symptomatic patients with nonobstructive coronary artery disease. JOURNAL OF NUCLEAR CARDIOLOGY. 21:453-466.Full Text via DOI: 10.1007/s12350-014-9865-9 PMID: 24683047
-
2014Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET. JOURNAL OF NUCLEAR CARDIOLOGY. 21:233-244.Full Text via DOI: 10.1007/s12350-013-9820-1 PMID: 24482141
-
2013Influence of Race/Ethnic Differences in Pre-Transplantation Panel Reactive Antibody on Outcomes in Heart Transplant Recipients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 62:2308-2315.Full Text via DOI: 10.1016/j.jacc.2013.06.054 PMID: 23994416
-
2013Influence of Sex on Risk Stratification With Stress Myocardial Perfusion Rb-82 Positron Emission Tomography Results From the PET (Positron Emission Tomography) Prognosis Multicenter Registry. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 62:1866-1876.Full Text via DOI: 10.1016/j.jacc.2013.06.017 PMID: 23850903
-
2013POLYPILL STRATEGY FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISORDERS. DRUGS OF TODAY. 317-324.Full Text via DOI: 10.1358/dot.2013.49.5.1950148 PMID: 23724411
Background
Full Name
- Naveen Bellam, MD
Education
- Joan C. Edwards School of Medicine at Marshall University
Residency
- Emory University Hospital; Emory University
Fellowship
- University of California, Los Angeles (UCLA)
Board Certification
- American Board of Internal Medicine
Contact
primary email
- Research.Institute@AdventHealth.com